利用统一血管框架预测系统性硬化症器官特异性并发症并实现疾病修饰
本文为Personal View,阐述系统性硬化症中免疫介导的血管内皮损伤是早期病理特征,可同时累及多器官但早期常仅表现为雷诺现象。文章描述各血管表现间的相互关系,提出建立统一血管概念框架,以开发预测性复合指数指导预防性干预,并构建统一血管复合终点模型以捕捉未来血管活性药物治疗试验中有临床意义的疾病修饰。
要点
- 免疫介导的血管内皮损伤被认为是系统性硬化症最早期的病理特征之一。
- 明显的血管表现包括雷诺现象、甲襞毛细血管形态异常、指端溃疡、肺动脉高压等。
- 组织缺血可能促进异常组织重塑,导致钙质沉着和纤维化。
核心结论
- 系统性硬化症中血管并发症之间存在显著相互关系,可据此建立统一血管概念框架以指导预防性干预和临床试验终点设计。
研究设计与样本
- 本文为Personal View,未报告系统检索范围或样本量。
主要发现
- 免疫介导的血管内皮损伤被认为同时发生于广泛器官,但早期临床上通常仅表现为雷诺现象。
- 明显的血管系统性硬化症表现包括雷诺现象、甲襞毛细血管形态异常、指端溃疡、肺动脉高压、心血管疾病(原发性和冠状动脉性)、毛细血管扩张、肾危象和胃窦血管扩张症。
- 组织缺血可能促进异常组织重塑,导致钙质沉着和纤维化。
- 针对指端血管病变的血管治疗干预对其他器官血管有靶外获益的案例已有报道。
- 危及生命的血管并发症如肺动脉高压的治疗通常直到可分类的器官疾病发生后才开始。
关键数值与推荐
- 原文未报告具体诊断标准、数值阈值或推荐等级。
临床怎么用
- 识别稳健的预后生物标志物可能通过预防性疾病修饰避免危及生命的血管并发症。
- 统一血管概念框架可用于开发预测性复合指数以指导预防性干预。
- 统一血管复合终点模型可用于未来血管活性药物治疗试验中有效捕捉有临床意义的疾病修饰。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immune-mediated vascular endothelial injury is considered one of the earliest pathological features in systemic sclerosis and is thought to occur simultaneously within a broad range of organs, although typically clinically manifesting only as Raynaud's phenomenon in the early stages. Overt vascular systemic sclerosis manifestations include Raynaud's phenomenon, abnormal nailfold capillary morphology, digital ulcers, pulmonary arterial hypertension, cardiovascular disease (primary and coronary), telangiectasia, renal crisis, and gastric antral vascular ectasia. Tissue ischaemia might also contribute to aberrant tissue remodelling, resulting in calcinosis and fibrosis. Recognition of the substantial inter-relationship between these vascular complications is growing; examples of vascular treatment interventions targeting digital vasculopathy having off-target vascular benefits in other organs have been reported. In general, treatment of life-threatening vascular complications, such as pulmonary arterial hypertension, is not commenced until classifiable organ disease has occurred; however, the identification of robust prognostic biomarkers might allow such complications to be averted with preventative disease modification. In this Personal View, we describe the inter-relationship between vascular features of systemic sclerosis. We consider how these features might be exploited to establish a unified vascular conceptual framework that can inform the development of both predictive composite indices to guide preventative intervention, and a unified vascular composite endpoint model that can effectively capture clinically meaningful disease modification in future clinical trials of vasoactive treatments in systemic sclerosis.
引用
- Pauling JD, Allanore Y, Buch MH, et al. Exploiting a unified vascular framework to predict organ-specific complications and accomplish disease modification in systemic sclerosis. Lancet Rheumatol. 2025. PMID: 41106412. doi:10.1016/S2665-9913(25)00251-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。